Search This Blog

Tuesday, January 12, 2021

Citigroup Downgrades Sarepta Therapeutics to Neutral from Buy

 Target $108

https://www.marketscreener.com/quote/stock/SAREPTA-THERAPEUTICS-INC-11204214/news/Sarepta-Therapeutics-Citigroup-Downgrades-Sarepta-Therapeutics-to-Neutral-from-Buy-Sets-108-Pric-32178716/

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)